These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15693794)

  • 21. Prenatal diagnosis of X-linked chronic granulomatous disease by percutaneous umbilical blood sampling.
    Sun J; Wang Y; Liu D; Yu Y; Wang J; Ying W; Wang X
    Scand J Immunol; 2012 Nov; 76(5):512-8. PubMed ID: 22924737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of two anti-gp91phox antibodies as immunoprobes for Nox family proteins: mAb 54.1 recognizes recombinant full-length Nox2, Nox3 and the C-terminal domains of Nox1-4 and cross-reacts with GRP 58.
    Baniulis D; Nakano Y; Nauseef WM; Banfi B; Cheng G; Lambeth DJ; Burritt JB; Taylor RM; Jesaitis AJ
    Biochim Biophys Acta; 2005 Sep; 1752(2):186-96. PubMed ID: 16140048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease.
    Cotugno N; Finocchi A; Cagigi A; Di Matteo G; Chiriaco M; Di Cesare S; Rossi P; Aiuti A; Palma P; Douagi I
    J Allergy Clin Immunol; 2015 Mar; 135(3):753-61.e2. PubMed ID: 25175493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91phox.
    Yamauchi A; Yu L; Pötgens AJ; Kuribayashi F; Nunoi H; Kanegasaki S; Roos D; Malech HL; Dinauer MC; Nakamura M
    Microbiol Immunol; 2001; 45(3):249-57. PubMed ID: 11345535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox.
    Patiño PJ; Perez JE; Lopez JA; Condino-Neto A; Grumach AS; Botero JH; Curnutte JT; García de Olarte D
    Hum Mutat; 1999; 13(1):29-37. PubMed ID: 9888386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
    Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
    Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina.
    Barese C; Copelli S; Zandomeni R; Oleastro M; Zelazko M; Rivas EM
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):656-60. PubMed ID: 15454837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of neutrophil NADPH oxidase activity reconstituted in a cell-free assay using specific monoclonal antibodies raised against cytochrome b558.
    Batot G; Martel C; Capdeville N; Wientjes F; Morel F
    Eur J Biochem; 1995 Nov; 234(1):208-15. PubMed ID: 8529642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-step immunoaffinity purification and functional reconstitution of human phagocyte flavocytochrome b.
    Lord CI; Riesselman MH; Gripentrog JM; Burritt JB; Jesaitis AJ; Taylor RM
    J Immunol Methods; 2008 Jan; 329(1-2):201-7. PubMed ID: 17996248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).
    Gérard B; El Benna J; Alcain F; Gougerot-Pocidalo MA; Grandchamp B; Chollet-Martin S
    Hum Mutat; 2001 Aug; 18(2):163. PubMed ID: 11462241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of Nox2 N-terminus using polyclonal antipeptide antibodies.
    Paclet MH; Henderson LM; Campion Y; Morel F; Dagher MC
    Biochem J; 2004 Sep; 382(Pt 3):981-6. PubMed ID: 15233623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H; Ishibashi F
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
    Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.
    Li XJ; Fieschi F; Paclet MH; Grunwald D; Campion Y; Gaudin P; Morel F; Stasia MJ
    J Leukoc Biol; 2007 Jan; 81(1):238-49. PubMed ID: 17060362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic granulomatous disease. Molecular genetics.
    Dinauer MC; Orkin SH
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncompetitive inhibition of superoxide generation by a synthetic peptide corresponding to a predicted NADPH binding site in gp91-phox, a component of the phagocyte respiratory oxidase.
    Tsuchiya T; Imajoh-Ohmi S; Nunoi H; Kanegasaki S
    Biochem Biophys Res Commun; 1999 Apr; 257(1):124-8. PubMed ID: 10092521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody 7D5 raised to cytochrome b558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their carrier mothers.
    Nakamura M; Murakami M; Koga T; Tanaka Y; Minakami S
    Blood; 1987 May; 69(5):1404-8. PubMed ID: 3552074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91(phox) resulting in the rare X91(+) variant of chronic granulomatous disease.
    Boog B; Quach A; Costabile M; Smart J; Quinn P; Singh H; Gold M; Booker G; Choo S; Hii CS; Ferrante A
    Hum Mutat; 2012 Mar; 33(3):471-5. PubMed ID: 22125116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.